| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/02/2012 | US20120027848 Enzyme Delivery Systems and Methods of Preparation and Use |
| 02/02/2012 | US20120027847 Cell lines and their use in encapsulated cell biodelivery |
| 02/02/2012 | US20120027846 Anti-viral azide containing compounds |
| 02/02/2012 | US20120027845 Adenovirus AD36 E4 ORF1 Protein For Prevention and Treatment of Non-Alcoholic Fatty Liver Disease |
| 02/02/2012 | US20120027844 Compounds, their syntheses, compositions, and methods to treat cancer |
| 02/02/2012 | US20120027843 Hb-egf bound protein complex |
| 02/02/2012 | US20120027842 Topical formulations of flap inhibitors for administration to an eye |
| 02/02/2012 | US20120027841 Novel mucosal vaccination approach for herpes simplex virus type-2 |
| 02/02/2012 | US20120027840 Adhesive patch and patch preparation |
| 02/02/2012 | US20120027839 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 02/02/2012 | US20120027838 Filaments comprising an ingestible active agent nonwoven webs and methods for making same |
| 02/02/2012 | US20120027837 Multilayer coating compositions, coated substrates and methods thereof |
| 02/02/2012 | US20120027836 Novel edwardsiella ictaluri e-ict-vl33 strain, vaccines thereof, and a method for protecting fishes using said vaccines |
| 02/02/2012 | US20120027835 Surgical prosthesis having biodegradable and nonbiodegradable regions |
| 02/02/2012 | US20120027833 Drug-eluting films |
| 02/02/2012 | US20120027827 Method and Composition for Reducing Exhaled Carbon Dioxide Emissions |
| 02/02/2012 | US20120027826 Free-Flowing Emulsion Concentrates |
| 02/02/2012 | US20120027825 Method of preparing lipid nanoparticles |
| 02/02/2012 | US20120027824 Preparations facilitated by vesicles using alkyl polypentosides and uses of said preparations |
| 02/02/2012 | US20120027823 Methods of treatment using a gastric retained gabapentin dosage |
| 02/02/2012 | US20120027822 Process for Producing Rapidly Disintegrating Spheroids (Pellets), Granules and/or Mixtures Thereof |
| 02/02/2012 | US20120027821 Amino acid-conjugated cyanoacrylate polymer particles |
| 02/02/2012 | US20120027820 Stable Formulations for Lyophilizing Therapeutic Particles |
| 02/02/2012 | US20120027819 Medical Devices Incorporating a Bioactive and Methods of Preparing Such Devices |
| 02/02/2012 | US20120027818 Bisphosphonate product in a cycloolefinic polymer container |
| 02/02/2012 | US20120027817 Absorbable Implants and Methods for Their Use in Hemostasis |
| 02/02/2012 | US20120027816 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity |
| 02/02/2012 | US20120027815 Use of plasma membrane calcium atpase (pmca) inhibitors to inhibit sperm mobility |
| 02/02/2012 | US20120027813 Adjuvanted influenza vaccines for pediatric use |
| 02/02/2012 | US20120027812 Intraocular lenses treated with alkylphosphocholines for pharmacological aftercataract prophylaxis |
| 02/02/2012 | US20120027811 Formulations of Viable Cells for Oral Delivery |
| 02/02/2012 | US20120027810 Patch production |
| 02/02/2012 | US20120027809 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof |
| 02/02/2012 | US20120027808 Nicotine immunonanotherapeutics |
| 02/02/2012 | US20120027807 Tissue engineered myocardium and methods of production and uses thereof |
| 02/02/2012 | US20120027806 Dose selection of adjuvanted synthetic nanocarriers |
| 02/02/2012 | US20120027805 Controlled-Released Peptide Formulations |
| 02/02/2012 | US20120027804 Medical product, in particular for management of tissue repair |
| 02/02/2012 | US20120027797 Preservation of Bioactive Materials by Freeze Dried Foam |
| 02/02/2012 | US20120027694 Inducible release vehicles |
| 02/02/2012 | US20120027693 Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise |
| 02/02/2012 | US20120027692 Pyrrolopyrimidinedione and its therapeutic use |
| 02/02/2012 | US20120027691 Cinnamic Acid-Based Oligomers and Uses Thereof |
| 02/02/2012 | US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method |
| 02/02/2012 | US20120027688 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 02/02/2012 | US20120027681 Low-Aspect Ratio Carbon Nanostructures |
| 02/02/2012 | US20120027675 Targeting pulmonary epithelium using adrp |
| 02/02/2012 | US20120024743 Transdermal pharmaceutical preparations |
| 02/02/2012 | DE19839515B4 Neue pharmazeutische Zubereitung, enthaltend kolloidale Polymer-Wirkstoff-Assoziate, insbesondere auch für mucosale Wirkstoffverabreichung New pharmaceutical preparation containing colloidal polymer-drug associates, especially for mucosal drug delivery |
| 02/02/2012 | CA2807084A1 Preservative free brimonidine and timolol solutions |
| 02/02/2012 | CA2807081A1 Preservative free bimatoprost and timolol solutions |
| 02/02/2012 | CA2807065A1 Drug support body, and method for producing same |
| 02/02/2012 | CA2806982A1 Compounds and methods for skin repair |
| 02/02/2012 | CA2806973A1 Preservative free bimatoprost solutions |
| 02/02/2012 | CA2806823A1 Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids |
| 02/02/2012 | CA2806737A1 Dispersions of rasagiline citrate |
| 02/02/2012 | CA2806428A1 Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
| 02/02/2012 | CA2806351A1 Compositions comprising polymers prepared from 2-hydroxyalkyl acids |
| 02/02/2012 | CA2806153A1 Compositions for treating heartworm infestation |
| 02/02/2012 | CA2806133A1 Compositions for controlling heartworm infestation |
| 02/02/2012 | CA2806009A1 A transmucosal composition containing anthocyanins for alleviating a visual discomfort |
| 02/02/2012 | CA2805864A1 Stabilization of fsh |
| 02/02/2012 | CA2805445A1 Pharmaceutical and/or dietary compositions based on short chain fatty acids |
| 02/02/2012 | CA2804855A1 Pharmaceutical compositions containing pemetrexed having extended storage stability |
| 02/02/2012 | CA2804715A1 Composition comprising shellac and/or a salt thereof and sodium starch glycolate |
| 02/01/2012 | EP2412431A1 Dispersion and manufacturing method therefor |
| 02/01/2012 | EP2412386A1 Adhesion preventing composition, solid preparation and method for producing same |
| 02/01/2012 | EP2412385A1 Liquid formulation of FSH |
| 02/01/2012 | EP2412384A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 02/01/2012 | EP2412377A1 Burdock fruit extract containing arctigenin at high content and process for producing same |
| 02/01/2012 | EP2412370A1 Matrix-type sustained release preparation containing basic additive |
| 02/01/2012 | EP2412369A1 Coated solid preparation |
| 02/01/2012 | EP2412368A1 Method and composition for the treatment of scars |
| 02/01/2012 | EP2412367A1 Solid preparation |
| 02/01/2012 | EP2412366A1 Solid preparation |
| 02/01/2012 | EP2412242A2 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 02/01/2012 | EP2411521A1 Compositions for stimulation of mammalian innate immune resistance to pathogens |
| 02/01/2012 | EP2411087A1 Binary and tertiary galvanic particulates and methods of manufacturing and use thereof |
| 02/01/2012 | EP2411065A2 Implantable medical devices coated with nucleic acid-encapsulating liposome |
| 02/01/2012 | EP2411052A2 Carrier comprising a vitamin e derivative |
| 02/01/2012 | EP2411020A2 Compositions and methods for treatment of hemorrhage |
| 02/01/2012 | EP2411017A2 Parenteral pharmaceutical composition for use in gene therapy |
| 02/01/2012 | EP2411013A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions |
| 02/01/2012 | EP2410999A2 Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions |
| 02/01/2012 | EP2410998A2 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| 02/01/2012 | EP2410997A1 Composition for the administration of polymeric drugs |
| 02/01/2012 | EP2410996A2 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| 02/01/2012 | EP2410995A1 Orodispersible tablets |
| 02/01/2012 | EP2410994A1 Pharmaceutical composition containing levodopa, entacapone and carbidopa |
| 02/01/2012 | EP2410993A1 Use of date syrup as a binder |
| 02/01/2012 | EP2410992A1 Ascorbate-linked nanosystems for brain delivery |
| 02/01/2012 | EP2410991A1 Orally bioavailable lipid-based constructs |
| 02/01/2012 | EP2410990A1 Compositions and methods for enhancing contrast in imaging |
| 02/01/2012 | EP2410989A2 Cholesterol level lowering liposomes |
| 02/01/2012 | EP2410988A1 Pharmaceutical composition containing a drug and sirna |
| 02/01/2012 | EP2410987A1 Methods of treatment using combination therapy |
| 02/01/2012 | EP2410986A2 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
| 02/01/2012 | EP2410985A2 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis |
| 02/01/2012 | EP2410984A2 Anti-influenza formulations and methods |
| 02/01/2012 | EP2410983A2 Compositions and methods for preferential distribution of active agents to injury sites |